Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Lucyd Pte Ltd. Update

4 Jul 2018 07:00

RNS Number : 4692T
Tekcapital plc
04 July 2018
 

4 July 2018

Tekcapital plc

("Tekcapital" or the "Company")

 

Lucyd Pte Ltd. Appoints Dr Ira A. Clement as Science Advisor and

Files New Patent Application

 

Tekcapital plc (AIM: TEK), the UK intellectual property (IP) investment group focused on creating marketplace value from university technology, is pleased to announce that Lucyd Pte Ltd ("Lucyd") has appointed Dr Ira A. Clement, a licensed optometrist, as a science advisor and that it has filed a new patent application.

 

New appointment

 

Dr. Clement has over 40 years of experience in the practice of optometry. He has served as Past-President of the Westchester-Rockland-Putnam Optometric Society. As part of his pro bono activities, Dr Clement served as Past-President of the Suffern LIONS Club. Since its founding in 1917, Lions Clubs International® has worked on projects designed to prevent blindness, restore eyesight and improve eye health and eye care for hundreds of millions of people worldwide.

 

New Patent Application

 

On 2 July 2018, Lucyd announced the filing of a patent application No. 16/022,097 to improve the utility of Augmented Reality ("AR") glasses. The application is directed to smartglasses, with prescription lenses, and methods to control the presentation and display of information related to mobile device tasks that can be performed with these smartglasses.

 

Lucyd is delighted that Dr. Clement has joined the company's science advisory board. As a highly experienced optometrist, they believe their customers can benefit from his knowledgeable answers to questions regarding eye health. Additionally, Lucyd believes the new patent application may significantly enhance the ergonomics of AR glasses while maintaining a transparent interface.

 

Lucyd Pte Ltd is developing ergonomic smartglasses, blockchain apps and an eyewear e-shop to enhance the visual experience. To learn more about Lucyd, please visit www.lucyd.co.

 

Lucyd Pte Ltd is a subsidiary of Lucyd ltd, a Tekcapital portfolio company. Lucyd ltd is wholly owned by Tekcapital plc.

 

For further information please contact:

 

Tekcapital plc

Clifford M Gross, Ph.D.

 

Via Walbrook PR

 

finnCap Ltd (Nominated Adviser and Joint Broker)

+ 44 (0) 20 7220 0500

Geoff Nash / Max Bullen-Smith (Corporate Finance)

Alice Lane (ECM)

 

Dowgate Capital Stockbrokers (Joint Broker)

+44 (0) 1293 517744

David Poutney / James Serjeant

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Sam Allen / Nick Rome

tekcapital@walbrookpr.com

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

LEI: 213800GOJTOV19FIFZ85

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAXXLFBVDFZBBF
Date   Source Headline
5th Aug 20211:44 pmRNSNotification of Major Holding
5th Aug 20217:00 amRNSLucyd Appoints Non Executive Director
22nd Jul 20217:00 amRNSLucyd launches Crowdfund
5th Jul 202112:37 pmRNSNotification of Major Holdings
5th Jul 20217:00 amRNSLucyd Signs Canadian Distribution Agreement
1st Jul 20217:00 amRNSNotification of Investor Presentation
15th Jun 20212:05 pmRNSSecond Price Monitoring Extn
15th Jun 20212:00 pmRNSPrice Monitoring Extension
15th Jun 20217:00 amRNSGrant of Share Options
8th Jun 20217:00 amRNSNotice of Investor Presentation 8 June 2021
28th May 202110:40 amRNSResults of Annual General Meeting
28th May 20217:12 amRNSBelluscura First Day of Dealings on AIM
13th May 20217:00 amRNSNotice of AGM
10th May 20217:00 amRNSInvestor Presentation
7th May 20214:41 pmRNSSecond Price Monitoring Extn
7th May 20214:36 pmRNSPrice Monitoring Extension
7th May 20217:15 amRNSBelluscura Intention to Float on AIM
5th May 20217:00 amRNSPortfolio Company Update - Lucyd
4th May 20217:00 amRNSPortfolio Company Update - Guident
30th Apr 20217:00 amRNSFinal Results
1st Apr 20217:00 amRNSPortfolio Company Lucyd Update
31st Mar 20217:00 amRNSTotal Voting Rights
25th Mar 20217:00 amRNSNotification of Major Holdings
22nd Mar 20211:43 pmRNSNotification of Major Holdings
22nd Mar 20217:00 amRNSLucyd Signs Distribution Agreement
19th Mar 20214:21 pmRNSNotification of Major Holdings
19th Mar 202112:36 pmRNSNotification of Major Holdings
18th Mar 20219:05 amRNSSecond Price Monitoring Extn
18th Mar 20219:00 amRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSPlacing to raise £3.8 million
11th Mar 20217:00 amRNSSalarius update
8th Mar 20217:00 amRNSBelluscura FDA Clearance
5th Feb 20217:00 amRNSSalarius Update
4th Feb 20212:05 pmRNSSecond Price Monitoring Extn
4th Feb 20212:00 pmRNSPrice Monitoring Extension
2nd Feb 20212:47 pmRNSNotification of Major Shareholding
1st Feb 202111:05 amRNSSecond Price Monitoring Extn
1st Feb 202111:00 amRNSPrice Monitoring Extension
1st Feb 20219:05 amRNSSecond Price Monitoring Extn
1st Feb 20219:00 amRNSPrice Monitoring Extension
1st Feb 20217:00 amRNSCommencement of Trading OTCQB Venture Mkt in USA
12th Jan 20212:05 pmRNSSecond Price Monitoring Extn
12th Jan 20212:00 pmRNSPrice Monitoring Extension
6th Jan 20217:00 amRNSLucyd -Crowdfunding and launch Lyte E glasses
21st Dec 202012:35 pmRNSHolding(s) in Company
7th Dec 20202:49 pmRNSNotification of Major Holdings
3rd Dec 20203:46 pmRNSNotification of Major Holdings
3rd Dec 20209:05 amRNSSecond Price Monitoring Extn
3rd Dec 20209:00 amRNSPrice Monitoring Extension
3rd Dec 20207:00 amRNSBelluscura Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.